Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00658788 · ClinicalTrials.gov registry record · Phase 3
Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis
A Phase 3 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 3
- Development phase
- 305
- Enrollment target
NCT00658788 is a Phase 3 study that has completed, run by Galderma R&D. The registered enrollment target is 305 participants.
The verdict
NCT00658788, a Phase 3 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 305 participants
- Enrollment target
Study Summary
The primary objectives of this study are to evaluate the safety \& efficacy of consecutive treatments of Clobex® Spray and Silkis® Ointment in the management of plaque psoriasis.
Interventions
- DRUG clobetasol propionate spray 0.05%
- DRUG calcitriol ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00658788
The ClinicalTrials.gov registry entry for NCT00658788 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which clobetasol propionate spray 0.05% is the first listed.
NCT00658788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00658788 about?
NCT00658788 is a clinical study titled "Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis". The primary objectives of this study are to evaluate the safety \& efficacy of consecutive treatments of Clobex® Spray and Silkis® Ointment in the management of plaque psoriasis.
What is the current status of trial NCT00658788?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 305 participants. The study started on 2008-03. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00658788?
The interventions under investigation include: clobetasol propionate spray 0.05% (DRUG), calcitriol ointment (DRUG).
Who is sponsoring clinical trial NCT00658788?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.